We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
Cap. Flow
+$224M
Cap. Flow %
0.26%
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$72.5M
2
IWB icon
iShares Russell 1000 ETF
IWB
+$54.4M
3
BX icon
Blackstone
BX
+$44M
4
ABNB icon
Airbnb
ABNB
+$37.4M
5
EG icon
Everest Group
EG
+$30.9M

Sector Composition

Rank Sector Weight
1 Technology 26.73%
2 Healthcare 12.76%
3 Financials 12.67%
4 Consumer Discretionary 11.16%
5 Industrials 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDT icon
2476
IDT Corp
IDT
$1.6B
$572K ﹤0.01%
25,951
-12
-0% -$282
PWP icon
2477
Perella Weinberg Partners
PWP
$1.26B
$572K ﹤0.01%
56,180
+143
+0.3% +$1.46K
EQBK icon
2478
Equity Bancshares
EQBK
$1.04B
$572K ﹤0.01%
23,759
-411
-2% -$10.3K
UHAL icon
2479
U-Haul Holding Co
UHAL
$14.6B
$571K ﹤0.01%
10,470
-838
-7% -$48.7K
DJCO icon
2480
Daily Journal
DJCO
$795M
$571K ﹤0.01%
1,943
-18
-0.9% -$5.3K
ARTNA icon
2481
Artesian Resources
ARTNA
$355M
$571K ﹤0.01%
13,598
+418
+3% +$19.3K
GNLX icon
2482
Genelux
GNLX
$120M
$570K ﹤0.01%
23,274
+20,485
+734% +$519K
LXFR icon
2483
Luxfer Holdings
LXFR
$458M
$570K ﹤0.01%
43,670
+537
+1% +$6.78K
MRNS
2484
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$569K ﹤0.01%
70,705
+3,803
+6% +$31.6K
ALEC icon
2485
Alector
ALEC
$195M
$568K ﹤0.01%
87,681
-2,932
-3% -$19K
OLP
2486
One Liberty Properties
OLP
$521M
$568K ﹤0.01%
30,103
-15,603
-34% -$311K
DCGO icon
2487
DocGo
DCGO
$58.8M
$566K ﹤0.01%
106,207
-1,047
-1% -$8.5K
CWCO icon
2488
Consolidated Water Co
CWCO
$485M
$565K ﹤0.01%
19,882
+1,911
+11% +$47.1K
APLD icon
2489
Applied Digital
APLD
$8.65B
$565K ﹤0.01%
90,571
-1,447
-2% -$10.1K
BV icon
2490
BrightView Holdings
BV
$1.08B
$565K ﹤0.01%
72,888
-1,733
-2% -$13.8K
SLGC
2491
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$565K ﹤0.01%
236,279
+5,021
+2% +$11.1K
AGEN
2492
Agenus
AGEN
$276M
$564K ﹤0.01%
24,960
+279
+1% +$7.91K
AVNW icon
2493
Aviat Networks
AVNW
$271M
$563K ﹤0.01%
18,047
-98
-0.5% -$3.1K
STER
2494
DELISTED
Sterling Check Corp. Common Stock
STER
$563K ﹤0.01%
44,593
+7,487
+20% +$97K
KYO
2495
DELISTED
Kyocera Adr
KYO
$562K ﹤0.01%
10,971
+110
+1% +$5.63K
BAY
2496
DELISTED
BAYER AG SPONS ADR
BAY
$561K ﹤0.01%
46,757
+585
+1% +$7.02K
APGE icon
2497
Apogee Therapeutics
APGE
$10.2B
$561K ﹤0.01%
+26,320
New +$580K
NMR icon
2498
Nomura Holdings
NMR
$28.6B
$559K ﹤0.01%
139,072
+840
+0.6% +$3.35K
CAVA icon
2499
CAVA Group
CAVA
$7.23B
$559K ﹤0.01%
+18,238
New +$796K
UVE icon
2500
Universal Insurance Holdings
UVE
$1.21B
$554K ﹤0.01%
39,481
-66,987
-63% -$941K

Similar funds

RhumbLine Advisers's Q3 2023 Portfolio in Review

As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.

  • RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
  • RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
  • RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
  • RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
  • RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
  • RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
  • RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.

Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.